Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricDVADaVitaLHLabcorpDGXQuest Diagnostics
Snapshot
Price$209.68$254.43$193.58
Market cap$13.35B$20.98B$21.59B
Valuation
P/E17.1x22.3x21x
Forward P/E16x17.2x18.3x
Growth
Revenue growth6.7%7.3%11.0%
EPS growth6.6%30.2%14.9%
Profitability
Net margin5.7%6.7%9.1%
ROE181.2%10.9%14.1%
Balance sheet & cash
Debt / equity77.99x0.66x0.82x
Free cash flow yield8.2%5.2%5.4%
Dividend yield—1.1%1.7%
Verdict
Investment ratingNeutral· 53Favorable· 58Neutral· 57

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDVAtoday $210LHtoday $254DGXtoday $194
2027$167.65 – $245.89+17% CAGR$248.37 – $364.28+43% CAGR$166.79 – $244.62+26% CAGR
2028$178.74 – $262.15+12% CAGR$323.28 – $474.15+37% CAGR$191.61 – $281.02+20% CAGR
2029$190.55 – $279.48+10% CAGR$420.79 – $617.15+34% CAGR$220.12 – $322.84+19% CAGR
2030$203.15 – $297.95+9% CAGR$547.70 – $803.29+33% CAGR$252.87 – $370.88+18% CAGR
2031$216.57 – $317.64+9% CAGR$712.88 – $1,045.56+33% CAGR$290.50 – $426.06+17% CAGR
5-yr CAGR0.6% – 8.7%22.9% – 32.7%8.5% – 17.1%